Underdiagnosed and Undertreated: Pediatric Dermatology Pearls for Skin of Color
Diagnosing and treating pediatric patients with skin of color requires a nuanced eye and an understanding of unique psychosocial dynamics. At the latest Skin of Color Update (SOCU) conference, Dr. Karan Lal addressed these exact complexities. Written from the perspective of an attending dermatology resident, this summary breaks down Dr. Lal’s essential pearls across three major domains: pigmente …
Diagnosing and treating pediatric patients with skin of color requires a nuanced eye and an understanding of unique psychosocial dynamics. At the latest Skin of Color Update (SOCU) conference, Dr. Karan Lal addressed these exact complexities. Written from the perspective of an attending dermatology resident, this summary breaks down Dr. Lal’s essential pearls across three major domains: pigmente … Continue reading "Underdiagnosed and Undertreated: Pediatric Dermatology Pearls for Skin of Color"
Be excited about the new medications approved for use in pediatric patients, says Dr. A. Yasmine Kirkorian, chief of dermatology at Children’s National Hospital. Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. Kirkorian about the use of JAK inhibitors in children. Should dermatology clinicians prescribe JAK inhibitors in this patient … 
Explore the February 2024 issue of the Journal of Drugs in Dermatology! Discover groundbreaking research on topics such as novel treatments for melasma, advancements in psoriasis management, gene expression profile (GEP) testing for squamous cell carcinoma, pediatric vitiligo, and many more! Stay ahead of the curve with the latest insights from leading dermatology experts. Straight from the Editor …